The 16 dermatomyositis antibodies include anti-amyl tRNA synthetase antibody, anti-MDA5 antibody, anti-Mi-2 antibody, anti-TIF1γ antibody, anti-NXP2 antibody, anti-SAE antibody, anti-SRP antibody, anti-HMGCR antibody, anti-RO52 antibody, anti-RO60 antibody and so on.
1. Anti-amyl tRNA synthetase antibodies: including anti-Jo-1 antibody, PL-7, PL-12, EJ, OJ, KS, Zo, YRS antibodies, etc.
2. MDA5 antibody: commonly found in patients with myasthenia gravis dermatomyositis.
3. Anti-Mi-2 antibody: people who are positive for this antibody tend to have skin rashes.
4. Anti-TIF1γ antibody: the antibody-positive patients can see skin rash, sunburn erythema, etc.
5. anti-NXP2 antibody: the antibody is positive, the rash and muscle lesions are more serious, in addition, the antibody is positive, suggesting that there is a greater correlation with malignant tumors.
6. Anti-SAE antibody: the antibody is positive for severe skin lesions and hyperpigmented rash.
7. Anti-SRP antibody: the antibody positive person has poor muscle strength.
8. Anti-HMGCR antibody: the antibody positive person has obvious muscle weakness.
9. In addition, there are anti-RO52 antibody, anti-RO60 antibody, anti-La antibody, anti-PM-Scl antibody, anti-Ku antibody, anti-U1RNP antibody, anti-cN-1A antibody and so on.
The above are dermatomyositis-specific antibodies, and it is recommended that patients should consult with the rheumatology and immunology departments for detailed information.